Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis B

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

458 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder

NCT01847430

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

GSK Investigational Site Tuttlingen, Baden-Wurttemberg, Germany

GSK Investigational Site Bindlach, Bavaria, Germany

GSK Investigational Site Kirchheim, Bavaria, Germany

View Trial Details

Completed

Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children

NCT01138098

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Banská Bystrica, Slovakia

GSK Investigational Site Dolný Kubín, Slovakia

GSK Investigational Site Dubnica nad Váhom, Slovakia

GSK Investigational Site Martin, Slovakia

View Trial Details

Completed

Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults

NCT00289770

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations: GSK Investigational Site Wilrijk, Belgium

View Trial Details

Completed

Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination

NCT00684671

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations: GSK Investigational Site Wilrijk, Belgium

GSK Investigational Site Hradec Králové, Czechia

View Trial Details

Completed

Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

NCT00317135

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

NCT00317187

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site Bangkok, Thailand

View Trial Details

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

NCT01627340

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations: GSK Investigational Site Huntsville, Alabama, United States

GSK Investigational Site Stockbridge, Georgia, United States

GSK Investigational Site Boise, Idaho, United States

GSK Investigational Site Mishawaka, Indiana, United States

View all 22 locations

View Trial Details

Completed

Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)

NCT01463683

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Not specified

View Trial Details

Completed

Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases

NCT01988753

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +18 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)

NCT01300234

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: GSK Investigational Site Guangzhou, Guangdong, China

GSK Investigational Site Guangzhou, Guangdong, China

GSK Investigational Site Guangzhou, Guangdong, China

GSK Investigational Site Wuhan, Hubei, China

View all 20 locations

View Trial Details